[ad_1]
PharmStars focuses on bridging the “pharma-startup gap” to help pharma and startups overcome partnership barriers. PharmStars’ unique PharmaU program provides education and mentorship to help startups more effectively partner with pharma.
The 11 members of the Fall 2022 cohort were selected in August 2022 following a highly competitive application process that attracted 75 applicants from 13 different countries. The selected startups each offer a unique digital health solution related to Real World Evidence. Their diverse array of digital health solutions includes novel remote patient monitoring techniques, new biomarkers, drug discovery tools, analytics tools, data annotation platforms, therapeutic-area data models, and novel RWE datasets.
At the Showcase Event, startups presented their solutions to PharmStars’ pharma members. The startups then had the chance to participate in one-on-one meetings with the members. More than 60 meetings took place over two days. Participating startups said the Showcase Event was extremely valuable and useful to their business.
Zainab Doctor, Vice President for Product at nference said, “I can’t imagine a way we could have gotten this far this quickly with so many pharma in parallel without deploying a much larger sales force.”
Startup CEO, Sameer Sontakey of Biostrap said, “Every single customer conversation at the Showcase was excellent. These have been the best one-on-ones that I’ve had with any pharma clients.”
The CEO of another, international startup agreed that the Showcase Event led to actionable next steps. “We walked away from the Showcase with immediate action items and continued conversations with everyone we met,” said Katheron Intson, CEO of Varient.
The following 11 digital health startups completed the Fall 2022 PharmStars accelerator:
· Biostrap (Austin, TX): High-Resolution, Biosensor-based Digital Biomarker Platform
· Celero Systems (Lincoln, MA): Continuous, Ingestible, One-Week, Physiological Monitoring Platform
· Centaur Labs (Boston, MA): Scalable Data Annotation Platform for the Life Sciences
· Citadel Discovery (Cambridge, MA): AI Platform Using DNA-Encoded Libraries (DELs) for Drug Discovery
· Huma.AI (Palo Alto, CA): Powerful, User-Friendly Natural Language Processing Platform Optimized for the Generation of RWE
· nference (Cambridge, MA): RWE Generation Platform Built on 11+ million Academic Medical Center Medical Records
· Promptly Health (Porto, Portugal): Advanced Analytics Engine that Harmonizes Real-World Data to Generate Insights
· Scienta Lab (Paris, France): AI-Powered Platform for Auto-immune Diseases Modeling at the Patient Level
· uMed (London, England): Queryable, Dynamic Real-World Patient Cohorts for Prospective Population Research
· Unison (London, England): Genomics Data Brokerage Platform
· Varient (Toronto, Canada): Rare Disease Patient Community-Sourced Patient Reported Outcomes and RWE platform
For its Spring 2023 cohort, themed “Innovations in Women’s Health and Health Equity,” PharmStars is accepting applications until January 14, 2023. Digital health startups interested in participating can find information on dates and deadlines and the application form on the PharmStars website.
For pharma and biotech companies, PharmStars 2023 membership is now open to a limited number of additional firms.
About PharmStars
PharmStars is the member-based, pharma-focused accelerator for digital health startups. Through our extensive expertise across pharma, startups, digital health, and innovation, we understand the challenges that pharma and startups face when seeking to collaborate. Our PharmaU program supports digital health startups and our pharma members in “bridging the pharma-startup gap,” leading to greater success and faster adoption of “beyond the molecule” solutions for patients.
[ad_2]
Source link
